Drug Shortage Report for XANAX

Last updated on 2023-02-14 History
Report ID 162663
Drug Identification Number 00723770
Brand name XANAX
Common or Proper name Xanax
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) ALPRAZOLAM
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size BTL 100
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-04-04
Estimated end date Unknown
Actual end date 2023-01-20
Shortage status Resolved
Updated date 2023-02-14
Company comments Xanax 0.25mg & 0.5mg will remain available during this period.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2023-02-14 French Compare
v14 2023-02-14 English Compare
v13 2023-01-17 French Compare
v12 2023-01-17 English Compare
v11 2022-11-29 French Compare
v10 2022-11-29 English Compare
v9 2022-09-01 French Compare
v8 2022-09-01 English Compare
v7 2022-08-01 French Compare
v6 2022-08-01 English Compare
v5 2022-07-04 French Compare
v4 2022-07-04 English Compare
v3 2022-06-16 English Compare
v2 2022-06-15 French Compare
v1 2022-06-15 English Compare

Showing 1 to 15 of 15